Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03679559 · ClinicalTrials.gov registry record · NA
Exercise in Improving Health and Quality of Life in Breast Cancer Survivors
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT03679559: Completed NA study, sponsored by Roswell Park Cancer Institute.
NCT03679559 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 83 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03679559, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
This randomized pilot trial studies how well exercise works in improving health and quality of life in breast cancer survivors. Participating in an exercise program to maintain physical activity may help to improve health and quality of life in breast cancer survivors.
Primary Outcome
The feasibility outcomes will be assessed by a multivariable logistic regression model for the relative odds of remaining on the study (ref: not). Each of the active treatment arms will be compared to the control. The model will be supported by the randomized patient set, counting patients who withdraw from the study as feasibility failures. No variable selection steps will be taken; inferences will be based on the estimates and 95% confidence intervals from the full model. Optimism adjusted odd
Interventions
- OTHER Best Practice
- OTHER Informational Intervention
- BEHAVIORAL Exercise Intervention (home walking program and resistance training)
- BEHAVIORAL Exercise Intervention (home-based Zumba program and resistance training)
- BEHAVIORAL Exercise Intervention (HIIT program and resistance training)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2017-10-06 |
| Est. Completion | 2022-06-02 |
| Phase | NA |
What the finished NCT03679559 record still lists
NCT03679559 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 5 interventions - of which Best Practice is the first listed.
NCT03679559 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03679559 about?
NCT03679559 is a clinical study titled "Exercise in Improving Health and Quality of Life in Breast Cancer Survivors". This randomized pilot trial studies how well exercise works in improving health and quality of life in breast cancer survivors. Participating in an exercise program to maintain physical activity may help to improve health and quality of life in breast cancer survivors.
What is the current status of trial NCT03679559?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2017-10-06. Estimated completion is 2022-06-02.
What interventions are being tested in trial NCT03679559?
The interventions under investigation include: Best Practice (OTHER), Informational Intervention (OTHER), Exercise Intervention (home walking program and resistance training) (BEHAVIORAL), Exercise Intervention (home-based Zumba program and resistance training) (BEHAVIORAL), Exercise Intervention (HIIT program and resistance training) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03679559?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03679559's enrollment target sits among peer trials
83 990th of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI